A multicenter phase II study of S-1 plus ramucirumab as first-line treatment in elderly patients with advanced/recurrent gastric cancer (KSCC1701).

被引：1
|
作者：
Katsuya, Hiroo
Suyama, Koichi
Kobayashi, Kazuma
Izawa, Naoki
Uenosono, Yoshikazu
Hu, Qingjiang
Kusumoto, Tetsuya
Otsu, Hajime
Orita, Hiroyuki
Kawanaka, Hirofumi
Shibao, Kazunori
Koga, Satoshi
Shimokawa, Mototsugu
Makiyama, Akitaka
Saeki, Hiroshi
Oki, Eiji
Baba, Hideo
Mori, Masaki
机构：
[1] Saga Univ, Saga, Japan
[2] Toranomon Gen Hosp, Tokyo, Japan
[3] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan
[4] St Marianna Univ, Dept Clin Oncol, Sch Med, Kawasaki, Kanagawa, Japan
[5] Imamura Gen Hosp, Kagoshima, Japan
[6] Kyushu Univ, Dept Surg & Sci, Grad Sch Med Sci, Fukuoka, Japan
[7] Natl Kyushu Med Ctr, Fukuoka, Japan
[8] Kyushu Univ, Beppu Hosp, Beppu, Oita, Japan
[9] Nakatsu Municipal Hosp, Nakatsu, Japan
[10] Natl Hosp Org Beppu Med Ctr, Beppu, Oita, Japan
[11] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka, Japan
[12] Iizuka Hosp, Iizuka, Fukuoka, Japan
[13] Yamaguchi Univ, Grad Sch Med, Dept Biostat, Yamaguchi, Japan
[14] Japan Community Healthcare Org Kyushu Hosp, Dept Hematol Oncol, Kitakyushu, Fukuoka, Japan
[15] Gunma Univ Hosp, Maebashi, Gumma, Japan
[16] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan
[17] Kyushu Univ, Dept Surg & Sci, Fukuoka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.4043
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4043
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A phase II multicenter trial assessing the efficacy and safety of first-line S-1 thorn ramucirumab in elderly patients with advanced/recurrent gastric cancer: KSCC1701
    Kobayshi, Kazuma
    Suyama, Koichi
    Katsuya, Hiroo
    Izawa, Naoki
    Uenosono, Yoshikazu
    Hu, Qingjiang
    Kusumoto, Tetsuya
    Otsu, Hajime
    Orita, Hiroyuki
    Kawanaka, Hirofumi
    Shibao, Kazunori
    Koga, Satoshi
    Shimokawa, Mototsugu
    Makiyama, Akitaka
    Saeki, Hiroshi
    Oki, Eiji
    Baba, Hideo
    Mori, Masaki
    [J]. EUROPEAN JOURNAL OF CANCER, 2022, 166 : 279 - 286
  • [2] Phase II study of S-1 in combination with paclitaxel as a first-line treatment for patients with advanced/recurrent gastric cancer
    Toh, U.
    Yamana, H.
    Koufuji, K.
    Mine, T.
    Aoyagi, K.
    Miyagi, M.
    Imaizumi, T.
    Shirouzu, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Phase II study of S-1 plus docetaxel as first-line treatment for elderly patients with advanced gastric cancer (OGSG0902).
    Matsuyama, Jin
    Imamura, Hiroshi
    Kawabata, Ryohei
    Kawase, Tomono
    Okada, Kazuyuki
    Nishikawa, Kazuhiro
    Kurokawa, Yukinori
    Fujitani, Kazumasa
    Shimokawa, Toshio
    Satoh, Taroh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [4] Geriatric-8 (G8) screening tool stratified the efficacy of S-1 plus ramucirumab in elderly patients with advanced/recurrent gastric cancer: A post-hoc analysis of the KSCC1701 trial
    Hu, Qingjiang
    Suyama, Koichi
    Kobayashi, Kazuma
    Katsuya, Hiroo
    Izawa, Naoki
    Uenosono, Yoshikazu
    Kusumoto, Tetsuya
    Otsu, Hajime
    Orita, Hiroyuki
    Kawanaka, Hirofumi
    Shibao, Kazunori
    Koga, Satoshi
    Shimokawa, Mototsugu
    Makiyama, Akitaka
    Saeki, Hiroshi
    Oki, Eiji
    Baba, Hideo
    Mori, Masaki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [5] Clinical Study of S-1 Plus Oxaliplatin Versus S-1 Plus Cisplatin as First-Line Treatment for Elderly Patients with Advanced Gastric Cancer
    Bo Deng-feng
    Hu Xiu-fu
    [J]. JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2015, 3 (04): : 238 - 242
  • [6] Docetaxel and S-1 as a First-line Treatment in Patients with Advanced or Recurrent Gastric Cancer
    Tsutani, Yasuhiro
    Ohara, Masahiro
    Suzuki, Takahisa
    Minami, Kazuhito
    Miyahara, Eiji
    Kameda, Akira
    Noso, Yoshihiro
    [J]. ANTICANCER RESEARCH, 2009, 29 (07) : 2775 - 2779
  • [7] Multicenter phase II trial of S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable colorectal cancer
    Shin, S.
    Park, Y.
    Kim, T.
    Oh, D.
    Shim, B.
    Lee, K.
    Lee, M.
    Kim, Y.
    Kim, Y.
    Ahn, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902)
    Tomono Kawase
    Hiroshi Imamura
    Ryohei Kawabata
    Jin Matsuyama
    Kazuhiro Nishikawa
    Kazuhiro Yanagihara
    Kazuyoshi Yamamoto
    Noriyuki Hoki
    Junji Kawada
    Hisato Kawakami
    Daisuke Sakai
    Yukinori Kurokawa
    Toshio Shimokawa
    Taroh Satoh
    [J]. International Journal of Clinical Oncology, 2024, 29 : 134 - 141
  • [9] Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902)
    Kawase, Tomono
    Imamura, Hiroshi
    Kawabata, Ryohei
    Matsuyama, Jin
    Nishikawa, Kazuhiro
    Yanagihara, Kazuhiro
    Yamamoto, Kazuyoshi
    Hoki, Noriyuki
    Kawada, Junji
    Kawakami, Hisato
    Sakai, Daisuke
    Kurokawa, Yukinori
    Shimokawa, Toshio
    Satoh, Taroh
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (02) : 134 - 141
  • [10] A phase II trial of oxaliplatin plus S-1 as a first-line chemotherapy for patients with advanced gastric cancer
    Yang Lin
    Song Yan
    Zhou Ai-ping
    Qin Qiong
    Chi Yihebali
    Huang Jing
    Wang Jin-wan
    [J]. CHINESE MEDICAL JOURNAL, 2013, 126 (18) : 3470 - 3474
12345